P

Inventor

HE JING

CN192 patents
⚠️ This page may combine multiple inventors who share the name “HE JING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENANTA PHARM INC

15 patents
US10683279B2Jun 16, 2020

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC13 citations94
US11560368B2Jan 24, 2023

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC6 citations86
US10988458B2Apr 27, 2021

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC7 citations84
US10683289B2Jun 16, 2020

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC10 citations84
US10597382B2Mar 24, 2020

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC10 citations84
US10457703B2Oct 29, 2019

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC8 citations84
US10450301B2Oct 22, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC11 citations84
US10450306B2Oct 22, 2019

Isoxazole analogs as FXR agonists and methods of use thereof

ENANTA PHARM INC7 citations84
US10253018B2Apr 9, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC10 citations84
US10246439B2Apr 2, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC12 citations84
US10208081B2Feb 19, 2019

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC9 citations84
US12018017B2Jun 25, 2024

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC1 citations73
US11958879B2Apr 16, 2024

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations73
US11834436B2Dec 5, 2023

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC2 citations73
US11718641B2Aug 8, 2023

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations73

SHENZHEN S HANDE TECH CO LTD

14 patents

FORD GLOBAL TECH LLC

6 patents

HE JING

5 patents

RIVIAN IP HOLDINGS LLC

3 patents

KLOBES OLAF

1 patent

NEUBORON MEDTECH LTD

1 patent

CHENGDU BOE OPTOELECT TECH CO

1 patent

VIVO MOBILE COMMUNICATION CO LTD

1 patent

SHENZHEN BEIBEI YOUPIN TECH CO LTD

1 patent

SHENZHEN HUOYU MEDIA CO LTD

1 patent

MALUUBA INC

1 patent

Showing the top 50 of 192 patents by PatentIndex Score.